Evolus

#EvolusInspires at MAIS2024! We’re excited to be at the first Medical Aesthetics Injectable Summit this weekend in Marbella, Spain. This congress is designed by Benjamin Ascher to bring together a diverse group of stakeholders with a passion for #aesthetics. Networking and exchanging scientific as well as business ideas is core to the program. If you are at MAIS, find our Evolus booth or catch Dr. Rui Avelar, MD (Evolus CMO), Umberto La Magna (SVP, Evolus International) or Maria Cudeiro (GM, Spain, Portugal and Switzerland) at their panel sessions. We’d love to connect. This is how we evolve the future of our industry. $EOLS #EvolveWithUs #PerformanceBeauty #MedicalAesthetics Our booth is organized and funded by Evolus. It’s for healthcare professionals and other relevant decision makers who are registered to attend the MAIS 2024 congress. Oct 2024

We are pleased to announce the appointment of Umberto La Magna as Senior Vice President of Evolus International and as a new member of the executive leadership team.    In this role, Umberto will lead our International organization as we continue to evolve and grow towards our #international revenue goal of $100M by 2028.    Umberto is a well-known and respected executive with more than 30 years of expertise in the medical device and pharmaceutical industry, with the last 22 years spent within medical #aesthetics. With extensive global and international experience, Umberto has lived and worked in Italy, France, the United Arab Emirates, Saudi Arabia, the Czech Republic, Switzerland and the UK. He is forward-thinking and customer oriented, with an inclusive, authentic leadership style.    Our values line up with his values and he will be a tremendous asset to our #culture.   Welcome to Evolus, Umberto! $EOLS #EvolveWithUs #PerformanceBeauty #MedicalAesthetics

We are thrilled to share that our CEO, David Moatazedi, has been recognized as a finalist by BeautyMatter for the NEXT 2024 Innovator of the Year! This acknowledgment is a testament to David’s visionary leadership and the entire Evolus team’s hard work, dedication, and relentless focus on revolutionizing the #aesthetics industry. Congratulations David – this is only the beginning! Read more about David’s journey and impact here: https://lnkd.in/eacW733j $EOLS #Evolus #EvolveWithUs #PerformanceBeauty #MedicalAesthetics

ICYMI: On September 12th, Evolus hosted an #InvestorDay in New York City, where we shared our bold vision for the future and engaged in insightful discussions with investors and analysts. It was a proud moment to showcase our growth trajectory, the excitement around our 2025 dermal filler launch, and our long-term goal of reaching at least $700 million in revenue by 2028.   To top if off, we had the privilege of ringing the Nasdaq closing bell on September 13th – an incredible milestone that symbolized the momentum we are building at Evolus.   A huge thanks to everyone who made these events a success – our team, investors, and partners. The future of #performancebeauty looks brighter than ever!   Investor Day Replay: https://lnkd.in/eWyZ-uJJ Nasdaq Closing Bell Ceremony: https://lnkd.in/e-BDYFJ2   $EOLS #Evolus #EvolveWithUs #PerformanceBeauty #MedicalAesthetics

This recent article from NewBeauty highlights the #innovative strides we are making with our Evolus Rewards program, which we discussed during our Investor Day on September 12th!   Club Evolus, the first manufacturer created subscription program, offers consumers increased access, unlocking new value, and eliminating friction, making it easier than ever to consistently receive the #beauty treatments they love.   Evolus continues to define #performancebeauty with our millennial-focused approach, bringing high-quality, cash-pay #aesthetic treatments to the younger generation.   Read the full article here: https://lnkd.in/eAqQ_rwm

What an unforgettable moment! Today, we had the honor of ringing the closing bell at the Nasdaq stock market. Our CEO, David Moatazedi led the ceremony alongside members of our executive team and employees. This was a proud moment for all of us at Evolus, a celebration of the hard work and dedication that has driven our success. We are excited to continue leading the way in performance beauty and building on the momentum we continue to drive in our business. Thank you to everyone who has been part of this journey with us. Here’s to even greater things ahead! Watch the full ceremony here: https://lnkd.in/eJz78vY $EOLS #Evolus #EvolveWithUs #PerformanceBeauty #MedicalAesthetics

What an unforgettable moment! Today, we had the honor of ringing the closing bell at the Nasdaq stock market. Our CEO, David Moatazedi led the ceremony alongside members of our executive team and employees. This was a proud moment for all of us at Evolus, a celebration of the hard work and dedication that has driven our success. We are excited to continue leading the way in performance beauty and building on the momentum we continue to drive in our business. Thank you to everyone who has been part of this journey with us. Here’s to even greater things ahead! Watch the full ceremony here: https://lnkd.in/eJz78vY $EOLS #Evolus #EvolveWithUs #PerformanceBeauty #MedicalAesthetics

Evolus is excited to share that we will be ringing the Nasdaq stock market closing bell on Friday, September 13th! The live broadcast will begin at 3:45 p.m. Eastern Time as our CEO David Moatazedi presides over the ceremony, joined by members of the company’s leadership team and guests. To view the broadcast, visit: https://lnkd.in/eJz78vY $EOLS #Evolus #EvolveWithUs #PerformanceBeauty #MedicalAesthetics

Looking back at David Moatazedi's insightful interview on the Schwab Network with Oliver Renick, it's amazing to see how far Evolus has come. During the conversation, David shared how Evolus has captured a significant 13% share of the market and built our brand as the fastest-growing neurotoxin for three consecutive years in the U.S. From expanding our presence in clinics to evolving beyond a single-product company, our journey has been defined by continuous #innovation. Our recent foray into dermal fillers is a testament to our commitment to becoming a leading multi-product #performance beauty brand. As we continue to build on this momentum, we're excited to share more about our growth trajectory and the strength of our business. We look forward to providing additional details on our vision for the future at our upcoming Investor Day on September 12th in New York City. Stay tuned! See the full interview here: https://lnkd.in/eKSnc7E9 Register here: https://lnkd.in/eTqAxXFr $EOLS #Evolus #EvolveWithUs #PerformanceBeauty #MedicalAesthetics

Evolus Elite Summit 2024 + Our top customers + Paris.   Some things are just better together, including our September advisory board with our top 50 customers. Together, we'll evolve the future of #beauty while gathering insights, sharing knowledge + previewing upcoming innovations. À tout à l'heure!   $EOLS #Evolus #EvolveWithUs #PerformanceBeauty #EliteSummit